Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PIII
PIII logo

PIII Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
3.080
Open
2.830
VWAP
2.98
Vol
20.55K
Mkt Cap
91.20M
Low
2.780
Amount
61.25K
EV/EBITDA(TTM)
--
Total Shares
--
EV
234.88M
EV/OCF(TTM)
--
P/S(TTM)
0.01
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
Show More

Events Timeline

(ET)
2026-03-27
09:00:00
Stock Futures Modestly Lower as Energy Prices Rise
select
2026-03-26 (ET)
2026-03-26
19:10:00
Nasdaq Index Enters Correction Territory as Energy Prices Rise
select
2026-03-26
16:10:00
P3 Reports Q4 Net Loss of $165.7 Million
select
2026-03-26
16:10:00
P3 Health Partners Sees FY26 Adjusted EBITDA of $20M-$40M
select
2025-11-13 (ET)
2025-11-13
17:36:13
P3 Health Partners Adjusts FY25 Revenue Forecast to $1.40-$1.45B, Up from $1.35B-$1.5B
select
2025-11-13
17:34:30
P3 Health Partners Announces Q3 Earnings Per Share of $9.67, Exceeding Consensus Estimate of $6.04
select
2025-08-14 (ET)
2025-08-14
16:16:02
P3 Health Partners sees FY25 revenue $1.35B-$1.5B, consensus $1.43B
select

News

seekingalpha
9.5
03-26seekingalpha
P3 Health Partners Q4 Earnings Report Analysis
  • Earnings Performance: P3 Health Partners reported a Q4 GAAP EPS of -$23.02, missing expectations by $13.56, indicating ongoing challenges in profitability that may negatively impact investor confidence.
  • Revenue Surge: The company achieved Q4 revenue of $384.8M, a staggering 1153.4% increase year-over-year, exceeding expectations by $27.15M, demonstrating strong market demand despite a slight decline from last year's $1.50B total revenue.
  • Medical Margin Improvement: The medical margin stood at $23.5M, or $17 PMPM, with normalized medical margin at $53.4M, reflecting progress in cost control and service efficiency, although the net loss reached $323.1M.
  • Future Guidance: For 2026, adjusted EBITDA is expected to range from -$20M to $40M, with a midpoint of $10M, indicating a projected year-over-year improvement of approximately $170M, showcasing management's confidence in future profitability.
moomoo
7.0
03-26moomoo
P3 Health Partners Inc. Projects Total Revenue Between $1.5 Billion and $1.7 Billion for 2026
  • Revenue Guidance: Health Partners Inc. has provided a total revenue guidance range for 2026, estimating between $1.5 billion and $1.7 billion.
moomoo
9.5
03-26moomoo
P3 Health Partners Reports Results for Fourth Quarter and Full Year 2025
  • Fourth Quarter Results: Health Partners has announced its results for the fourth quarter of 2025, highlighting key financial and operational metrics.

  • Full Year Performance: The organization also provided a comprehensive overview of its performance for the entire year of 2025, showcasing growth and achievements.

Newsfilter
9.5
03-13Newsfilter
P3 Health Partners to Release 2025 Financial Results on March 26, 2026
  • Earnings Release Announcement: P3 Health Partners Inc. plans to release its financial results for the fourth quarter and full year 2025 on March 26, 2026, reflecting the company's ongoing growth in healthcare management.
  • Conference Call Details: Management will host a conference call at 1:30 PM PT (4:30 PM ET) on the same day to discuss the financial results, enhancing communication with investors.
  • Live Webcast: The conference call will be webcast live in the 'Events & Presentations' section of P3's website, ensuring investors can access the latest company updates in real-time.
  • Investor Relations Support: P3 Health Partners will provide an archived recording of the webcast for 90 days post-conference, further supporting investors' understanding and analysis of the company's performance.
Newsfilter
7.5
2025-12-02Newsfilter
P3 Health Partners Forms Joint Venture with Commonwealth to Expand Value-Based Care
  • Joint Venture Formation: P3 Health Partners and Commonwealth Primary Care ACO have established a Joint Venture Management Services Organization aimed at expanding value-based care support across Arizona, California, Nevada, Oregon, and North Carolina, enhancing service capabilities for primary care physicians.
  • Market Expansion: This partnership expands P3's footprint into Maricopa County, Arizona, further solidifying its position in a key growth market, which is expected to drive business growth in the region.
  • Operational Efficiency Improvement: The joint venture combines P3's strengths in Medicare Advantage and ACO with Commonwealth's ACO REACH program to create a unified operational platform, thereby enhancing performance and efficiency in healthcare delivery.
  • Physician Support Enhancement: The joint venture will strengthen support for independent primary care physicians by sharing operations and best practices, ensuring they can thrive and deliver exceptional care in a value-based environment.
NASDAQ.COM
6.5
2025-11-04NASDAQ.COM
Projected Target Price for ONEQ Analyst: $104
  • ETF Performance Analysis: The Fidelity Nasdaq Composite Index ETF (ONEQ) has an implied analyst target price of $103.84, indicating a potential upside of 10.75% from its current trading price of $93.76.

  • Notable Holdings: Key underlying holdings with significant upside potential include KODIAK ROBOTICS INC (KDK), Red Cat Holdings Inc (RCAT), and P3 Health Partners Inc (PIII), with expected price increases of 96.58%, 62.44%, and 58.15% respectively.

  • Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they are based on outdated information.

  • Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analysts' targets in light of recent company and industry developments.

Wall Street analysts forecast PIII stock price to rise
4 Analyst Rating
Wall Street analysts forecast PIII stock price to rise
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
8.00
Averages
14.00
High
20.00
Current: 0.000
sliders
Low
8.00
Averages
14.00
High
20.00
Lake Street
Ben Haynor
Buy
maintain
$4
AI Analysis
2026-03-27
New
Reason
Lake Street
Ben Haynor
Price Target
$4
AI Analysis
2026-03-27
New
maintain
Buy
Reason
Lake Street analyst Ben Haynor lowered the firm's price target on P3 Health Partners to $4 from $12.50 and keeps a Buy rating on the shares. The transitional year of 2025 is "finally over, and 2026 looks far brighter," but higher-than-anticipated expenses in Q4 are "likely to leave the company in a situation where the balance sheet becomes an overriding investor concern," the analyst contends. However, despite likely investor balance sheet concerns, the firm sees "the management team making appropriate decisions and fully expect shares to exit this year on an entirely different trajectory once those concerns are resolved," the analyst added.
Lake Street
Buy
downgrade
$20
2025-11-17
Reason
Lake Street
Price Target
$20
2025-11-17
downgrade
Buy
Reason
Lake Street lowered the firm's price target on P3 Health Partners to $12.50 from $20 and keeps a Buy rating on the shares. Though Q3 aEBITDA results were "disappointing," P3 is "making progress, even if it is not yet evident in reported results," which should point to a much-improved 2026, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PIII
Unlock Now

Valuation Metrics

The current forward P/E ratio for P3 Health Partners Inc (PIII.O) is -0.33, compared to its 5-year average forward P/E of -5.97. For a more detailed relative valuation and DCF analysis to assess P3 Health Partners Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-5.97
Current PE
-0.33
Overvalued PE
3.24
Undervalued PE
-15.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.49
Current EV/EBITDA
-6.08
Overvalued EV/EBITDA
83.87
Undervalued EV/EBITDA
-88.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.19
Current PS
0.02
Overvalued PS
0.36
Undervalued PS
0.01

Financials

AI Analysis
Annual
Quarterly

Whales Holding PIII

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is P3 Health Partners Inc (PIII) stock price today?

The current price of PIII is 3.08 USD — it has increased 4.05

What is P3 Health Partners Inc (PIII)'s business?

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.

What is the price predicton of PIII Stock?

Wall Street analysts forecast PIII stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PIII is14.00 USD with a low forecast of 8.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is P3 Health Partners Inc (PIII)'s revenue for the last quarter?

P3 Health Partners Inc revenue for the last quarter amounts to 373.23M USD, decreased -3.93

What is P3 Health Partners Inc (PIII)'s earnings per share (EPS) for the last quarter?

P3 Health Partners Inc. EPS for the last quarter amounts to -314.11 USD, increased 3896.31

How many employees does P3 Health Partners Inc (PIII). have?

P3 Health Partners Inc (PIII) has 360 emplpoyees as of April 01 2026.

What is P3 Health Partners Inc (PIII) market cap?

Today PIII has the market capitalization of 91.20M USD.